Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2006-10-24
2006-10-24
Saeed, Kamal A. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S544000, C514S784000, C514S619000, C514S364000, C514S381000, C514S319000, C514S362000, C514S237500, C424S401000, C546S206000, C546S194000, C548S143000, C548S254000, C548S135000, C548S360100
Reexamination Certificate
active
07125869
ABSTRACT:
Novel polycyclic compounds having the structural formula (I) below:are formulated into pharmaceutical compositions suited for administration in human or veterinary medicine (in dermatology, and also in the fields of cardiovascular diseases, immune diseases and/or diseases associated with lipid metabolism), or, alternatively, into cosmetic compositions.
REFERENCES:
patent: 5739169 (1998-04-01), Ocain et al.
patent: WO 02/12210 (2002-02-01), None
Amakura, et al., “Acalyphidins M1, M2 and D1, ellagitannins from Acalypha hispida”, Phytochemistry 50(4), 1999, pp. 667-675.
XP-002278151, Copyright 1988-2001 Beilstein Institut zur Foerderung der Chemischen Wissenschaften.
French Search Report corresponding to FR 02/15751 issued on Aug. 20, 2003, 3 pages.
Clary Laurence
Collette Pascal
Jomard Andre
Rivier Michel
Barker Michael P.
Buchanan & Ingersoll & Rooney PC
Galderma Research & Development
Saeed Kamal A.
LandOfFree
Polycyclic compounds which modulate PPARγ type... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Polycyclic compounds which modulate PPARγ type..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Polycyclic compounds which modulate PPARγ type... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3707765